Skip to main content
Aller à la page d’accueil de la Commission européenne (s’ouvre dans une nouvelle fenêtre)
français fr
CORDIS - Résultats de la recherche de l’UE
CORDIS

Uncovering cell-type-specific neurodegeneration resilience mechanisms

Objectif

Neurodegenerative diseases (NDs) are an immense burden to patients, their families and society. For decades, they have been defined by two core characteristics. First, different NDs are characterized by the deposition of different toxic proteins in the nervous system, which are critical drivers of disease. Secondly, in different NDs different neuron subtypes are preferentially lost. Uncovering causal mechanisms explaining this selective neuronal vulnerability in NDs has remained difficult due to technical limitations. Here, I will comprehensively model this experimentally to establish the missing link and uncover the molecular mechanisms of how ND-causing toxic proteins cause selective neuronal vulnerability, and how resilient neurons survive. I will use an innovative Drosophila-human cross-species approach that I developed. As a discovery tool, we will perform parallelized single-cell RNA sequencing (scRNA-seq) of hundreds of different mature Drosophila neuron types that are exposed to defined amounts of toxic proteins. Based on the differential responses we will be able to build a holistic atlas of neuron-type-intrinsic vulnerability and resilience mechanisms in response to ND-causing toxic proteins. These will be computationally mapped to human, experimentally assessed in patient brains, and causal mechanisms established in in vivo modifier experiments in flies. We will also assess shared resilience mechanisms, since co-pathology of multiple toxic proteins is common. Therefore, we will employ concomitant protein detection and scRNA-seq to differentiate neuron-type-specific pathways that protect from toxic protein build-up vs. those that protect from the downstream cellular damage. Thereby, we will advance a fundamental scientific question and reverse engineer the brains‘ own resilience mechanisms for a new class of ND treatment targets.

Champ scientifique (EuroSciVoc)

Ce projet n'a pas encore été classé par EuroSciVoc.
Proposez les domaines scientifiques qui vous semblent les plus pertinents et aidez-nous à améliorer notre service de classification.

Mots‑clés

Programme(s)

Thème(s)

Régime de financement

HORIZON-ERC - HORIZON ERC Grants

Voir tous les projets financés dans le cadre de ce programme de financement

Appel à propositions

(s’ouvre dans une nouvelle fenêtre) ERC-2026-STG

Voir tous les projets financés au titre de cet appel

Institution d’accueil

MEDIZINISCHE UNIVERSITAT INNSBRUCK
Contribution nette de l'UE
€ 1 499 925,00
Adresse
CHRISTOPH PROBST PLATZ 1
6020 INNSBRUCK
Autriche
Région
Westösterreich Tirol Innsbruck
Type d’activité
Higher or Secondary Education Establishments
Liens
Coût total
€ 1 499 925,00

Bénéficiaires (1)